Cigna Investments’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $240K | Buy |
+671
| New | +$205K | 0.03% | 424 |
|
|
2025
Q1 | – | Sell |
-735
| Closed | -$241K | – | 462 |
|
|
2024
Q4 | $241K | Sell |
735
-22
| -3% | -$6.92K | 0.04% | 396 |
|
|
2024
Q3 | $228K | Sell |
757
-17
| -2% | -$5.21K | 0.04% | 409 |
|
|
2024
Q2 | $254K | Sell |
774
-13
| -2% | -$4.59K | 0.05% | 375 |
|
|
2024
Q1 | $311K | Hold |
787
| – | – | 0.06% | 333 |
|
|
2023
Q4 | $277K | Sell |
787
-18
| -2% | -$6.37K | 0.06% | 342 |
|
|
2023
Q3 | $302K | Sell |
805
-102
| -11% | -$39.4K | 0.07% | 307 |
|
|
2023
Q2 | $347K | Hold |
907
| – | – | 0.06% | 315 |
|
|
2023
Q1 | $314K | Sell |
907
-19
| -2% | -$5.55K | 0.06% | 330 |
|
|
2022
Q4 | $218K | Hold |
926
| – | – | 0.05% | 411 |
|
|
2022
Q3 | $228K | Sell |
926
-37
| -4% | -$11.3K | 0.05% | 384 |
|
|
2022
Q2 | $291K | Sell |
963
-345
| -26% | -$112K | 0.06% | 339 |
|
|
2022
Q1 | $537K | Sell |
1,308
-390
| -23% | -$153K | 0.07% | 296 |
|
|
2021
Q4 | $797K | Sell |
1,698
-650
| -28% | -$280K | 0.06% | 262 |
|
|
2021
Q3 | $998K | Sell |
2,348
-17
| -0.7% | -$7.17K | 0.07% | 247 |
|
|
2021
Q2 | $849K | Sell |
2,365
-357
| -13% | -$118K | 0.06% | 288 |
|
|
2021
Q1 | $767K | Buy |
2,722
+51
| +2% | +$14.6K | 0.05% | 327 |
|
|
2020
Q4 | $757K | Buy |
2,671
+273
| +11% | +$76.6K | 0.06% | 297 |
|
|
2020
Q3 | $659K | Hold |
2,398
| – | – | 0.06% | 278 |
|
|
2020
Q2 | $545K | Sell |
2,398
-385
| -14% | -$75.6K | 0.05% | 357 |
|
|
2020
Q1 | $424K | Sell |
2,783
-7,659
| -73% | -$1.18M | 0.05% | 363 |
|
|
2019
Q4 | $1.63M | Buy |
10,442
+8,146
| +355% | +$1.19M | 0.17% | 139 |
|
|
2019
Q3 | $331K | Buy |
2,296
+200
| +10% | +$27.5K | 0.03% | 502 |
|
|
2019
Q2 | $288K | Sell |
2,096
-100
| -5% | -$11.8K | 0.03% | 535 |
|
|
2019
Q1 | $243K | Sell |
2,196
-100
| -4% | -$10.4K | 0.03% | 592 |
|
|
2018
Q4 | $226K | Buy |
2,296
+51
| +2% | +$5.53K | 0.02% | 630 |
|
|
2018
Q3 | $238K | Sell |
2,245
-200
| -8% | -$22.4K | 0.02% | 639 |
|
|
2018
Q2 | $242K | Sell |
2,445
-4,021
| -62% | -$370K | 0.02% | 645 |
|
|
2018
Q1 | $571K | Sell |
6,466
-100
| -2% | -$9.36K | 0.04% | 402 |
|
|
2017
Q4 | $648K | Hold |
6,566
| – | – | 0.04% | 364 |
|
|
2017
Q3 | $633K | Buy |
6,566
+1,716
| +35% | +$155K | 0.04% | 369 |
|
|
2017
Q2 | $458K | Buy |
4,850
+1,961
| +68% | +$180K | 0.03% | 477 |
|
|
2017
Q1 | $236K | Buy |
2,889
+214
| +8% | +$17.9K | 0.02% | 661 |
|
|
2016
Q4 | $227K | Buy |
+2,675
| New | +$210K | 0.02% | 642 |
|
Other funds holding WST
GIM
Cigna Investments's WST Position: Q2 2026 in Review
Cigna Investments opened a new position in West Pharmaceutical (WST) in Q2 2026: 671 shares worth $240K. The stake represents 0.03% of the portfolio and ranks #424 among its holdings. This is a return to the name: Cigna Investments previously reported a position in WST as recently as Q4 2024.
Cigna Investments first reported a position in WST in Q4 2016 and has held it in 34 quarters since. The position peaked at $1.63M in Q4 2019. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- Cigna Investments held 671 shares of West Pharmaceutical worth $240K as of Q2 2026.
- West Pharmaceutical was a new Cigna Investments position in Q2 2026.
- West Pharmaceutical made up 0.03% of Cigna Investments's portfolio in Q2 2026, its #424 holding.
- Cigna Investments first reported a position in West Pharmaceutical in Q4 2016 and has held it in 34 quarters since.
- Cigna Investments's West Pharmaceutical position peaked at $1.63M in Q4 2019.
- 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.